Georges Gemayel PhD
Georges Gemayel, PhD, was appointed as a director of the Company effective March 23, 2015. Dr. Gemayel has more than 25 years of experience in the pharmaceutical industry, including management and executive positions spanning the United States, Europe and the Middle East and mostly at Roche, at Genzyme and Altus. Dr. Gemayel currently serves as Chairman of the Board of Directors of Oxthera, Enterome and Orphazyme, all privately held companies, and as Director of Raptor Pharmaceuticals (a NASDAQ listed company) and Dimension Therapeutics (a privately held company). He was previously a director of Adolor Corporation, FoldRx, Prosensa, Epitherapeutics, Syndexa, Vascular Magnetics and NPS Pharmaceuticals.